Key players in Multi-Cancer Early Detection
In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.
| # | Company | Website | Our reports |
|---|---|---|---|
| 1 | GRAIL | — | 66 reports |
| 2 | Exact Sciences Corporation | — | 132 reports |
| 3 |  Guardant Health, Inc. |
guardanthealth.com (opens in a new tab) | 165 reports |
| 4 | Freenome | — | 33 reports |
| 5 | Delfi Diagnostics | — | 33 reports |
Top trial sponsors in Multi-Cancer Early Detection
Companies leading the most active studies found with this market's trial search, worldwide (key players included).
Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Multi-Cancer Early Detection reports by place
Australia
Brazil
Canada
China
Ecuador
Egypt
France
Germany
Hong Kong
India
Italy
Japan
Kenya
Malaysia
Mexico
New Zealand
PhilippinesGet the full Multi-Cancer Early Detection report
Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.
Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.